Atom | High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Funder: National Institutes of Health

Funding Amounts: Up to $1.5M direct costs/year for up to 5 years; 1–2 awards per cycle; total project period max 5 years.

Summary: Supports interdisciplinary research teams pursuing transformative projects at the intersection of HIV and substance use, aiming to advance prevention, treatment, and cure among people who use drugs.

Key Information: Only teams of 3–6 PD/PIs are eligible; single-PI or dual-PI projects are not permitted.

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Sign in to see full grant listing